PostEra
PostEra is an AI-driven biopharma company based in Boston, founded in 2019. The company focuses on accelerating medicinal chemistry and drug discovery through its advanced machine learning platform, Proton. This technology enhances the discovery of new medicines by optimizing the design and development of small molecule drug candidates. PostEra develops its own drug candidates and engages in co-discovery partnerships with major pharmaceutical companies, including Amgen and Pfizer, as well as the National Institutes of Health (NIH). The company has led significant initiatives, such as the COVID Moonshot, aimed at accelerating antiviral treatment discovery. Its internal pipeline targets therapeutic areas like Women's Health and Fertility, while also collaborating on various preclinical programs.
Work at PostEra in HR or recruiting? Claim this page
Headcount trend
PostEra went from 34 employees in Oct 2024 to 39 in Sep 2026. Apr to Sep 2026: 1 people joined, 1 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Jan 2022 | Series A | $24M | 8 | |
| Dec 2021 | Funding | $26.1M | – | – |
| Mar 2020 | Seed | $150K | – | – |
Org structure
Headcount by department
Peer reviews
Worked with someone at PostEra?
Anonymous peer reviews on OffTheRecord
Similar companies
PostEra FAQ
How many employees does PostEra have?
PostEra has about 39 employees, up 2.6% over the 3 months to Sep 2026.
How much funding has PostEra raised?
PostEra has raised $50.2M in total funding; its latest round was Series A in Jan 2022.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.